Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AsiaMedicSGX:505 OCF Yield % is 14.69 as of Aug. 11, 2026, which is 47% above its 10-year median of 10.01. The stock has 4 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, AsiaMedic ranks better than 93.43% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for AsiaMedic's OCF Yield % or its related term are showing as below:
SGX:505'
s OCF Yield % Range Over the Past 10 Years
Min: -56.28 Med: 10.01 Max: 30.15
Current: 14.69
During the past 13 years, the highest OCF Yield % of AsiaMedic was 30.15%. The lowest was -56.28%. And the median was 10.01%.
SGX:505's OCF Yield % is ranked better than 93.43% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.26
vs SGX:505: 14.69
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
AsiaMedic OCF Yield % Related Terms
AsiaMedic OCF Yield % Historical Data
* Premium members only.
The historical data trend for AsiaMedic's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, AsiaMedic's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AsiaMedic OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, AsiaMedic's OCF Yield % distribution charts can be found below:
* The bar in red indicates where AsiaMedic's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AsiaMedic (SGX:505) has a OCF Yield % of 14.69 as of Aug. 11, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AsiaMedic and its competitors. This is 47% above median its historical median of 10.01. According to the industry distribution chart, AsiaMedic ranks #14 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 6.6%.
Is AsiaMedic's OCF Yield % too high?
AsiaMedic's current OCF Yield % of 14.69 is 47% above median its 10-year median of 10.01. The Medical Diagnostics & Research industry median OCF Yield % is 1.26. AsiaMedic's value of 14.69 is 1065.9% above this industry median. Based on the distribution chart, AsiaMedic ranks #14 out of 213 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does AsiaMedic's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, AsiaMedic ranks #14 out of 213 companies for OCF Yield %. This places AsiaMedic in the top 7% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.26. AsiaMedic's value of 14.69 is 1065.9% above this benchmark. While the company's 10-year median is 10.01 vs. the industry median of 1.26, AsiaMedic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.26, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AsiaMedic's current OCF Yield % of 14.69 is 1065.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on AsiaMedic and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AsiaMedic's current OCF Yield % is 14.69, which is 47% above median its own 10-year median of 10.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AsiaMedic stock overvalued right now?
Based on GuruFocus' analysis, AsiaMedic (SGX:505) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.02, compared to a current price of S$0.02 — trading 15% above its estimated fair value. The current OCF Yield % is 14.69, which is 47% above median its 10-year median of 10.01 and 1065.9% above the Medical Diagnostics & Research industry median of 1.26. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For AsiaMedic (SGX:505), the current OCF Yield % is 14.69 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AsiaMedic Ltd is an investment holding company. The principal activities of the company include the provision of management services. It engaged in the business of operating medical clinics in Singapore. It generates revenue from health screening and medical wellness services, diagnostic imaging and radiology services, primary care services and sales of pharmaceutical products, and medical aesthetic services and related products, net of discounts.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:505 has been successfully added to your 
